ImmunoGen, Inc. Announces Webcast Of Presentation At The Lazard Capital Markets Third Annual Life Sciences Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN) today announced that its presentation at the Lazard Capital Markets Third Annual Life Sciences Conference will be webcast live. The 25-minute presentation is scheduled to begin at 11:30 a.m. EST on November 28, 2006, and will be given at the New York Palace Hotel in New York City. The presentation will provide an update on ImmunoGen.